Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Sharon Pine

Concepts (308)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
32
2025
2642
2.920
 Why?
Carcinoma, Non-Small-Cell Lung
10
2025
1182
1.490
 Why?
Amyloid Precursor Protein Secretases
3
2018
77
1.140
 Why?
Biomarkers, Tumor
12
2025
1322
1.130
 Why?
SOX9 Transcription Factor
3
2023
28
1.100
 Why?
Leukemia, Megakaryoblastic, Acute
4
2007
10
0.810
 Why?
Receptor, Notch1
2
2014
64
0.790
 Why?
GATA1 Transcription Factor
4
2007
18
0.760
 Why?
DNA, Neoplasm
4
2010
164
0.710
 Why?
Janus Kinases
1
2021
20
0.710
 Why?
STAT Transcription Factors
1
2021
24
0.700
 Why?
Paclitaxel
2
2022
256
0.650
 Why?
Carcinoma, Squamous Cell
4
2025
642
0.620
 Why?
Signal Transduction
9
2021
5233
0.620
 Why?
Neoplastic Stem Cells
3
2013
412
0.570
 Why?
Inflammation
4
2022
2880
0.550
 Why?
Protease Inhibitors
1
2018
102
0.540
 Why?
Benzodiazepinones
1
2017
18
0.540
 Why?
Gene Expression Regulation, Neoplastic
9
2025
1462
0.520
 Why?
Neoplasms
4
2025
2884
0.510
 Why?
Cell Line, Tumor
13
2023
3550
0.500
 Why?
Antineoplastic Agents
7
2023
2197
0.490
 Why?
F-Box Proteins
1
2016
23
0.490
 Why?
Down Syndrome
4
2007
534
0.480
 Why?
Antineoplastic Agents, Phytogenic
1
2017
177
0.480
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
2005
293
0.480
 Why?
Proteasome Endopeptidase Complex
1
2016
159
0.450
 Why?
Polymerase Chain Reaction
5
2010
1054
0.440
 Why?
Drug Resistance, Neoplasm
6
2021
883
0.440
 Why?
Interleukin-8
3
2014
271
0.440
 Why?
Ubiquitin-Protein Ligases
1
2016
193
0.430
 Why?
Neoplasms, Basal Cell
1
2013
4
0.410
 Why?
Chromosome Segregation
1
2013
46
0.400
 Why?
DNA Damage
1
2016
430
0.400
 Why?
Cell Cycle Proteins
1
2016
629
0.370
 Why?
DNA
2
2022
1464
0.360
 Why?
Interleukin-6
3
2019
780
0.360
 Why?
C-Reactive Protein
2
2011
417
0.350
 Why?
Mannose-Binding Lectin
2
2009
20
0.340
 Why?
Adenocarcinoma
3
2017
931
0.340
 Why?
Smoking
6
2024
1472
0.330
 Why?
Proto-Oncogene Proteins c-mdm2
2
2012
66
0.330
 Why?
Oncogene Proteins, Fusion
3
2017
211
0.320
 Why?
Humans
52
2025
144957
0.320
 Why?
Case-Control Studies
14
2024
3608
0.310
 Why?
Cell Transformation, Neoplastic
2
2021
339
0.310
 Why?
Mutation
9
2023
4099
0.300
 Why?
Polymorphism, Single Nucleotide
6
2019
2147
0.290
 Why?
Mice
12
2023
18365
0.280
 Why?
Polymorphism, Genetic
2
2009
612
0.280
 Why?
Cytokines
1
2015
2065
0.270
 Why?
Proto-Oncogene Proteins p21(ras)
3
2023
253
0.260
 Why?
Inflammation Mediators
2
2021
509
0.260
 Why?
Lymphoma, AIDS-Related
1
2007
14
0.260
 Why?
Molecular Targeted Therapy
2
2021
434
0.250
 Why?
Lymphoproliferative Disorders
1
2007
57
0.250
 Why?
Leukemia
2
2007
245
0.250
 Why?
Animals
14
2023
38109
0.240
 Why?
Lymphoma, Non-Hodgkin
1
2007
124
0.230
 Why?
Nuclear Weapons
1
2025
7
0.230
 Why?
Cell Proliferation
7
2021
2499
0.230
 Why?
Neoplasms, Radiation-Induced
1
2025
99
0.220
 Why?
Female
31
2025
78376
0.200
 Why?
Carboplatin
2
2022
160
0.200
 Why?
Breast Neoplasms
2
2013
2456
0.200
 Why?
Smokers
1
2024
137
0.200
 Why?
Tumor Microenvironment
3
2023
735
0.190
 Why?
Genes, ras
1
2023
96
0.190
 Why?
Aged
19
2024
25947
0.190
 Why?
Central Nervous System Neoplasms
1
2005
174
0.190
 Why?
Alternative Splicing
1
2025
249
0.180
 Why?
Base Sequence
4
2014
2191
0.180
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2022
109
0.180
 Why?
Intracellular Signaling Peptides and Proteins
2
2022
460
0.180
 Why?
Cell Movement
3
2020
965
0.180
 Why?
Epithelial-Mesenchymal Transition
2
2014
220
0.180
 Why?
Pyrazines
1
2022
93
0.170
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2022
139
0.170
 Why?
Ribosome Subunits, Large, Eukaryotic
1
2021
3
0.170
 Why?
Superoxide Dismutase-1
1
2021
10
0.170
 Why?
Organelle Biogenesis
1
2021
15
0.170
 Why?
Immunity, Innate
1
2007
846
0.170
 Why?
Cytokinesis
1
2021
50
0.170
 Why?
Triazoles
1
2022
184
0.170
 Why?
Adenocarcinoma, Mucinous
1
2021
76
0.160
 Why?
Middle Aged
18
2024
35928
0.160
 Why?
Receptors, Kisspeptin-1
1
2020
2
0.160
 Why?
Phosphatidylinositol 3-Kinases
1
2022
381
0.160
 Why?
Proto-Oncogene Proteins c-akt
1
2022
437
0.160
 Why?
Molecular Sequence Data
3
2014
2931
0.160
 Why?
Prognosis
7
2024
4293
0.160
 Why?
Receptor-Like Protein Tyrosine Phosphatases, Class 2
1
2019
9
0.160
 Why?
Male
25
2025
72406
0.160
 Why?
Disease Susceptibility
1
2021
348
0.160
 Why?
Janus Kinase 2
1
2019
29
0.150
 Why?
Molecular Chaperones
1
2021
200
0.150
 Why?
Mice, Inbred NOD
2
2020
610
0.150
 Why?
Cellular Senescence
2
2013
226
0.150
 Why?
Cellular Reprogramming
1
2020
103
0.150
 Why?
Neoplasm, Residual
3
2005
139
0.150
 Why?
TOR Serine-Threonine Kinases
1
2022
451
0.150
 Why?
Biomarkers
2
2021
4275
0.140
 Why?
Acrylamides
1
2019
70
0.140
 Why?
Combined Modality Therapy
1
2021
1268
0.140
 Why?
Nanotechnology
1
2019
126
0.140
 Why?
Aniline Compounds
1
2019
119
0.140
 Why?
Proteolysis
2
2016
173
0.140
 Why?
Carcinogenesis
1
2020
229
0.130
 Why?
Risk Factors
8
2015
10792
0.130
 Why?
Quinolines
1
2019
193
0.130
 Why?
Receptors, Notch
1
2018
92
0.130
 Why?
Quinazolines
1
2019
266
0.130
 Why?
Transfection
2
2017
940
0.130
 Why?
Tumor Suppressor Protein p53
2
2013
531
0.130
 Why?
Disease Management
1
2021
647
0.130
 Why?
Transcriptome
1
2024
1046
0.130
 Why?
Lung
4
2022
4109
0.130
 Why?
CD24 Antigen
2
2013
18
0.130
 Why?
Triple Negative Breast Neoplasms
1
2020
216
0.130
 Why?
F-Box-WD Repeat-Containing Protein 7
1
2016
6
0.120
 Why?
Cancer Survivors
1
2022
327
0.120
 Why?
Neoplasm Invasiveness
2
2020
509
0.120
 Why?
Hyaluronan Receptors
2
2013
102
0.120
 Why?
Glycogen Synthase Kinase 3 beta
1
2016
72
0.120
 Why?
Ubiquitination
1
2016
118
0.120
 Why?
Coculture Techniques
2
2013
246
0.120
 Why?
Proportional Hazards Models
2
2011
1325
0.120
 Why?
Protein Interaction Domains and Motifs
1
2016
148
0.120
 Why?
Cell Division
3
2013
766
0.110
 Why?
Proto-Oncogene Proteins B-raf
1
2017
226
0.110
 Why?
Receptors, Interleukin-8B
1
2014
23
0.110
 Why?
Cell Death
1
2016
383
0.110
 Why?
Protein Isoforms
2
2013
402
0.110
 Why?
Computational Biology
1
2019
681
0.110
 Why?
Tumor Cells, Cultured
2
2021
919
0.110
 Why?
Protein Kinase Inhibitors
2
2019
970
0.110
 Why?
Patient Selection
1
2018
719
0.100
 Why?
Gene Expression Profiling
4
2025
1786
0.100
 Why?
3' Untranslated Regions
1
2014
152
0.100
 Why?
Software
1
2019
692
0.100
 Why?
Disease Progression
1
2021
2852
0.100
 Why?
Energy Metabolism
1
2020
936
0.100
 Why?
Ultraviolet Rays
1
2016
388
0.100
 Why?
Platinum Compounds
1
2013
11
0.100
 Why?
Colorectal Neoplasms
1
2021
848
0.100
 Why?
Genes, T-Cell Receptor
2
2003
6
0.100
 Why?
Research Design
2
2011
1137
0.100
 Why?
Dipeptides
1
2013
57
0.100
 Why?
Core Binding Factor Alpha 2 Subunit
2
2003
30
0.100
 Why?
Immunoglobulin Heavy Chains
2
2003
85
0.090
 Why?
Models, Biological
2
2019
1822
0.090
 Why?
Alleles
3
2014
881
0.090
 Why?
Lymphocytes, Tumor-Infiltrating
1
2013
154
0.090
 Why?
Gene Expression Regulation
1
2021
2609
0.090
 Why?
Survival Analysis
2
2013
1385
0.090
 Why?
Stromal Cells
1
2012
125
0.090
 Why?
Gap Junctions
1
2012
67
0.090
 Why?
Genotype
4
2014
1835
0.090
 Why?
Phosphorylation
1
2016
1733
0.090
 Why?
HIV Infections
1
2007
3154
0.090
 Why?
National Cancer Institute (U.S.)
1
2011
52
0.090
 Why?
Bone Marrow Cells
1
2012
320
0.090
 Why?
Risk Assessment
3
2011
3676
0.090
 Why?
Japan
2
2025
143
0.080
 Why?
Cell Communication
1
2012
324
0.080
 Why?
Melanoma
1
2017
761
0.080
 Why?
ROC Curve
2
2024
615
0.080
 Why?
AC133 Antigen
1
2010
20
0.080
 Why?
Protein Binding
1
2016
2276
0.080
 Why?
Adult
8
2020
40506
0.080
 Why?
Bromodeoxyuridine
1
2010
79
0.080
 Why?
Phenotype
3
2013
3164
0.080
 Why?
Biopsy
2
2017
1077
0.070
 Why?
Logistic Models
2
2011
2119
0.070
 Why?
Exons
2
2008
358
0.070
 Why?
Infant
3
2007
10039
0.070
 Why?
DNA Replication
1
2010
251
0.070
 Why?
Glycoproteins
1
2010
355
0.070
 Why?
Genetic Predisposition to Disease
4
2012
2365
0.070
 Why?
Polymorphism, Single-Stranded Conformational
1
2007
26
0.070
 Why?
Cell Differentiation
2
2008
2050
0.070
 Why?
Baltimore
1
2007
71
0.070
 Why?
CD8-Positive T-Lymphocytes
1
2013
917
0.060
 Why?
Tobacco Smoke Pollution
1
2009
233
0.060
 Why?
Smoking Cessation
1
2011
439
0.060
 Why?
Sequence Homology, Nucleic Acid
1
2007
157
0.060
 Why?
Linkage Disequilibrium
1
2007
247
0.060
 Why?
Prospective Studies
2
2011
7997
0.060
 Why?
Antigens, CD
1
2010
555
0.060
 Why?
Autophagy
2
2023
286
0.060
 Why?
DNA Primers
2
2008
512
0.060
 Why?
Superoxide Dismutase
1
2008
301
0.060
 Why?
Infant, Newborn
3
2007
6434
0.060
 Why?
ErbB Receptors
2
2019
629
0.060
 Why?
Neoplasm Staging
3
2017
1465
0.060
 Why?
In Situ Hybridization, Fluorescence
1
2007
323
0.060
 Why?
Haplotypes
1
2007
490
0.060
 Why?
Predictive Value of Tests
1
2011
2118
0.060
 Why?
Disease-Free Survival
1
2007
769
0.060
 Why?
Chromosomes, Human, Pair 21
1
2005
42
0.060
 Why?
Gene Knockdown Techniques
2
2021
336
0.060
 Why?
Preservation, Biological
1
2005
7
0.060
 Why?
Remission Induction
1
2005
308
0.050
 Why?
Liquid Biopsy
1
2024
14
0.050
 Why?
United States
3
2020
15988
0.050
 Why?
Cloning, Molecular
1
2005
541
0.050
 Why?
History, 21st Century
1
2025
219
0.050
 Why?
MicroRNAs
3
2019
701
0.050
 Why?
Tobacco Smoking
1
2024
26
0.050
 Why?
History, 20th Century
1
2025
325
0.050
 Why?
Mice, Knockout
2
2021
3125
0.050
 Why?
Peptides
1
2010
998
0.050
 Why?
Chronology as Topic
1
2003
2
0.050
 Why?
Chromosome Breakage
1
2003
23
0.050
 Why?
Reproducibility of Results
2
2019
3415
0.050
 Why?
Gene Expression
1
2008
1490
0.050
 Why?
Mitogen-Activated Protein Kinase Kinases
1
2023
128
0.050
 Why?
Clone Cells
1
2003
266
0.050
 Why?
Mucins
1
2022
76
0.050
 Why?
Apoptosis
2
2021
2430
0.040
 Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2003
89
0.040
 Why?
Immunophenotyping
1
2003
322
0.040
 Why?
Promoter Regions, Genetic
1
2006
1258
0.040
 Why?
Cell Nucleolus
1
2021
20
0.040
 Why?
Child
4
2009
22657
0.040
 Why?
Adenosine
1
2022
255
0.040
 Why?
RNA Processing, Post-Transcriptional
1
2021
92
0.040
 Why?
Mutagenesis, Site-Directed
1
2021
381
0.040
 Why?
Down-Regulation
1
2022
627
0.040
 Why?
Aftercare
1
2022
224
0.040
 Why?
Glutaminase
1
2020
11
0.040
 Why?
Time Factors
1
2011
7183
0.040
 Why?
Fibrosis
1
2022
548
0.040
 Why?
Precision Medicine
1
2024
458
0.040
 Why?
RNA Precursors
1
2021
156
0.040
 Why?
Africa, Western
1
2019
21
0.040
 Why?
Mice, Nude
1
2021
688
0.040
 Why?
A549 Cells
1
2019
75
0.040
 Why?
Tumor Stem Cell Assay
1
2019
34
0.040
 Why?
Glutamine
1
2020
109
0.040
 Why?
Recurrence
1
2003
1135
0.040
 Why?
Exome
1
2020
227
0.040
 Why?
Nucleotides
1
2020
128
0.040
 Why?
Mice, SCID
1
2020
369
0.040
 Why?
Child, Preschool
2
2005
11799
0.040
 Why?
Killer Cells, Natural
1
2022
469
0.040
 Why?
DNA Mutational Analysis
1
2019
409
0.040
 Why?
Tumor Burden
1
2020
322
0.040
 Why?
Incidence
2
2019
2883
0.040
 Why?
Proto-Oncogene Proteins c-myc
1
2020
167
0.030
 Why?
Survivors
1
2022
520
0.030
 Why?
Xenograft Model Antitumor Assays
1
2021
930
0.030
 Why?
STAT3 Transcription Factor
1
2019
207
0.030
 Why?
Cell Nucleus
1
2021
619
0.030
 Why?
Immunotherapy
1
2022
657
0.030
 Why?
Genetic Therapy
1
2019
313
0.030
 Why?
B-Lymphocytes
1
2003
877
0.030
 Why?
DNA-Binding Proteins
1
2005
1500
0.030
 Why?
Risk
1
2019
911
0.030
 Why?
Young Adult
3
2020
14126
0.030
 Why?
Transcription Factors
1
2005
1742
0.030
 Why?
Health Status Disparities
1
2019
321
0.030
 Why?
Positron Emission Tomography Computed Tomography
1
2017
117
0.030
 Why?
Follow-Up Studies
2
2019
5417
0.030
 Why?
Pyrimidines
1
2019
533
0.030
 Why?
Indoles
1
2019
501
0.030
 Why?
MAP Kinase Signaling System
1
2017
311
0.030
 Why?
Neoplasm Metastasis
1
2017
695
0.030
 Why?
Survival Rate
1
2019
2092
0.030
 Why?
Leupeptins
1
2013
13
0.030
 Why?
Cell Survival
1
2017
1098
0.030
 Why?
Macrolides
1
2013
69
0.020
 Why?
Transduction, Genetic
1
2013
133
0.020
 Why?
Octamer Transcription Factor-3
1
2012
19
0.020
 Why?
Ligands
1
2014
674
0.020
 Why?
Binding Sites
1
2014
1331
0.020
 Why?
Neoplasm Proteins
1
2013
444
0.020
 Why?
Cohort Studies
2
2012
5965
0.020
 Why?
Recombinant Proteins
1
2013
1371
0.020
 Why?
Disease Models, Animal
1
2021
4569
0.020
 Why?
Mice, Inbred C57BL
1
2021
5997
0.020
 Why?
Cross-Sectional Studies
1
2022
5872
0.020
 Why?
Genetic Variation
1
2014
984
0.020
 Why?
Confidence Intervals
1
2010
333
0.020
 Why?
Early Detection of Cancer
1
2014
466
0.020
 Why?
Age Distribution
1
2010
403
0.020
 Why?
Sex Distribution
1
2010
386
0.020
 Why?
Treatment Outcome
1
2024
11695
0.020
 Why?
Small Cell Lung Carcinoma
1
2010
119
0.020
 Why?
Reference Values
1
2010
798
0.020
 Why?
Enzyme Stability
1
2008
73
0.020
 Why?
Adolescent
2
2009
22453
0.020
 Why?
Homozygote
1
2008
199
0.020
 Why?
Neoplasm Recurrence, Local
1
2014
1141
0.020
 Why?
Linear Models
1
2010
854
0.020
 Why?
Odds Ratio
1
2010
1077
0.020
 Why?
Amino Acid Substitution
1
2008
304
0.020
 Why?
Colonic Neoplasms
1
2009
260
0.020
 Why?
Aged, 80 and over
1
2019
8279
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2008
983
0.010
 Why?
Cells, Cultured
1
2013
4155
0.010
 Why?
Erythroid-Specific DNA-Binding Factors
1
2005
17
0.010
 Why?
Comorbidity
1
2010
1660
0.010
 Why?
Environmental Exposure
1
2009
590
0.010
 Why?
Aneuploidy
1
2005
91
0.010
 Why?
Genome-Wide Association Study
1
2010
1407
0.010
 Why?
Retrospective Studies
1
2014
17101
0.010
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2005
1958
0.010
 Why?
Pine's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (308) concept(s)
_
Co-Authors Expand Description
See all (9) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)